Sichuan Huiyu Pharmaceutical Co.Ltd(688553) : Sichuan Huiyu Pharmaceutical Co.Ltd(688553) announcement on resignation of directors and by election of non independent directors of the first board of directors

Securities code: Sichuan Huiyu Pharmaceutical Co.Ltd(688553) securities abbreviation: Sichuan Huiyu Pharmaceutical Co.Ltd(688553) Announcement No.: 2022025 Sichuan Huiyu Pharmaceutical Co.Ltd(688553)

Announcement on resignation of directors and by election of non independent directors of the first board of directors

The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.

On April 6, 2022, Sichuan Huiyu Pharmaceutical Co.Ltd(688553) (hereinafter referred to as “the company”) held the 22nd Meeting of the first board of directors, deliberated and adopted the proposal on resignation of directors and by election of non independent directors of the first board of directors. The board of directors unanimously agreed to nominate Ms. Wu Ying as a candidate for non independent director of the first board of directors of the company. After being appointed as a non independent director with the consent of the general meeting of shareholders, she will also serve as a member of the strategy committee of the board of directors of the company, and her term of office is the same as that of the current board of directors, that is, from the date of deliberation and approval by the general meeting of shareholders to the date of expiration of the term of office of the current board of directors. The details are hereby announced as follows:

1、 Resignation of directors

The board of directors of the company recently received a written resignation from Ms. Lin Zhen, a director of the company and a member of the strategy committee of the board of directors. Ms. Lin Zhen submitted to the board of directors for personal reasons to resign as a director of the company (corresponding to resigning as a member of the Strategy Committee of the board of directors). According to the company law, the Sichuan Huiyu Pharmaceutical Co.Ltd(688553) articles of association and other relevant provisions, Ms. Lin Zhen’s resignation as a director will not cause the number of the board of directors of the company to be lower than the legal minimum and will not affect the normal operation of the company. Ms. Lin Zhen’s resignation will take effect from the date of reaching the board of directors. After her resignation, Ms. Lin Zhen will no longer hold any position in the company.

Ms. Lin Zhen has been a director of the company since March 2020. During her tenure, Ms. Lin Zhen has strictly implemented the relevant laws and regulations of listed companies, performed her duties according to law, and made great contributions to the standardized operation of the board of directors. The company and the board of directors thank her for her hard work and contributions in recent years!

2、 Nomination of directors and review procedures

Recommended by Shanghai shuangsa enterprise management consulting firm (limited partnership), the shareholder holding more than 5% of the company’s shares, and approved by the nomination committee of the board of directors, the company held the 22nd Meeting of the first board of directors on April 6, 2022, and deliberated and adopted the proposal on Resignation of directors and by election of non independent directors of the first board of directors. The board of directors unanimously agreed to nominate Ms. Wu Ying as a candidate for non independent director of the first board of directors of the company. After being appointed as a non independent director with the consent of the general meeting of shareholders, she will also serve as a member of the strategy committee of the board of directors of the company, and her term of office is the same as that of the current board of directors, that is, from the date of deliberation and approval by the general meeting of shareholders to the date of expiration of the term of office of the current board of directors.

Ms. Wu Ying has professional knowledge and practical work experience in line with the actual needs of the company; Have the qualification and ability to serve as a director of the company; There is no circumstance stipulated in the company law and Sichuan Huiyu Pharmaceutical Co.Ltd(688553) articles of association that the company is unable to serve as a director of the company. Ms. Lin Zhen, the former director, has a mother daughter relationship with Ms. Wu Ying. See the attachment for the resume of Ms. Wu Ying.

3、 Opinions of independent directors

Ms. Wu Ying has professional knowledge and practical work experience in line with the actual needs of the company; Have the qualification and ability to serve as a director of the company; There is no circumstance stipulated in the company law and Sichuan Huiyu Pharmaceutical Co.Ltd(688553) articles of association that the company is unable to serve as a director of the company. Up to now, Ms. Wu Ying has not directly held the company’s shares, has no relationship with other shareholders holding more than 5% of the company’s shares, other directors, supervisors and senior managers of the company, has not been punished by the CSRC and other relevant departments or the stock exchange, has not been suspected of committing a crime and has not been filed for investigation by the judicial organ or filed for investigation by the CSRC for violation of laws and regulations, and is not a dishonest person, Qualifications that meet the requirements of relevant laws, administrative regulations, departmental rules and normative documents. The nomination and deliberation procedures of director candidates are legal and compliant, and there is no situation that damages the interests of shareholders, especially minority shareholders. We unanimously agree to the proposal and agree to submit it to the general meeting of shareholders of the company for deliberation.

It is hereby announced.

Sichuan Huiyu Pharmaceutical Co.Ltd(688553) board of directors April 7, 2022 attachment: resume of Ms. Wu Ying

Wu Ying, female, born in June 1973, Chinese nationality, without permanent residency abroad, graduated from high school. Since June 2011, he has served as executive director and general manager of Hangzhou Youfu Trading Co., Ltd; Since April 2014, he has served as executive director and general manager of Fuzhou Yidong Sports Culture Development Co., Ltd.

- Advertisment -